| Views | |
|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 229 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 5 | 13 | 0 | 2 | 2 | 3 | 2 |
| Views | |
|---|---|
| 2021_Yu_etal.pdf | 111 |
